Bobby Iman Setya

PlanB Capital (PlanB Capital) is a venture capital firm founded in 1900. The firm is headquartered in India.

Omnify, Inc. operates software as a service (SaaS) platform for small and medium enterprises. It offers recreational centers and parks, pool and swim clubs, gym and fitness, yoga and wellness, and retail solutions. The company was founded by Manik Mehta and Kabandi Saikia and is headquartered in Mountain View, CA.

Leaf Innovation Pvt Ltd. Engages in manufacturing of audio products. The firm’s products include leaf flex wireless neckband earphones, leaf pods true wireless earbuds, leaf dash wired earphone, and leaf rock wired headphones. The company is headquartered in New Delhi, India.

General Organization for Social Insurance (Saudi Arabia) (GOSI) is the Government of Saudi Arabia's body which was established by Royal Decree in 1969 to apply and regulate social insurance, a form of social protection for private sector workers (and a category of workers in the public sector) which provides for workers and their families after termination of employment due to retirement, disability or death. It also provides medical care for occupational injuries and diseases and compensation for occupational disability or death. GOSI is a semi-state body which is supervised by a board of directors consisting of the Minister of Labor, GOSI Governor, members representing Ministry of Labor, Ministry of Finance and Ministry of Health, qualified insured members and employers' members. Based in Riyadh, the Organization also has field offices distributed throughout the Kingdom's provinces and districts.

Abzena (Cambridge) Ltd. provides antibody engineering and immunogenicity screening services. The company was founded in 2004 and is headquartered in Babraham, the United Kingdom.

Arquer Diagnostics Ltd. develops proprietary diagnostic immunoassays for the detection of prostate and bladder cancer using urine samples. Its develops non-invasive, urine-based ELISA and Point-of Care tests meet the increased demand for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes. The firm will commercialise ELISA and point-of-care urine tests for prostate and bladder cancer for use in the urology clinic, hospital lab and the GP’s surgery. The company was founded by David Nicholas Miller-Jones and William Dawson in 2007 and is headquartered in Sunderland, the United Kingdom.

Eli Lilly & Co. Ltd. provides pharmaceutical health care solutions. It provide products for cardiovascular, dermatology, diabetes, endocrine, musculoskeletal, neuroscience, oncology and urology. The company was incorporated on April 9, 1963 and is headquartered in Basingstoke, the United Kingdom.

The Royal Society of Chemistry is an organization that supports the chemical sciences community in making the world a better place. The Royal Society of Chemistry is based in London, UK, and has subsidiaries in the United Kingdom. The British company offers various opportunities in education, inclusion, and chemistry's ability to tackle challenges. The organization aims to advance excellence, connect chemical scientists, and shape the future of the chemical sciences for the benefit of humanity. The private company has a publishing portfolio that contains over one million articles, chapters, and records from across the chemical sciences and related fields. The company also provides solutions to help businesses engage with their audience of chemical scientists.

Part of Meridian Co., Ltd., Bionet Co., Ltd. develops and manufactures patient monitoring and fetal monitoring systems. The company is based in Seoul, South Korea. Bionet Co. was acquired by Meridian Co., Ltd. on June 24, 2003.

UBS AG (London Branch) is the Great Britain-based brokerage subsidiary of UBS AG, ultimately held by UBS Group AG (SWX: UBSG) in Switzerland. Headquartered in London, the firm was founded in 1998 and provides nimble, innovative and bespoke access to solutions, from market and insight tools, to trading strategies and execution for private, institutional and corporate clients worldwide, as well as private clients in Switzerland. They distribute, trade, finance and clear cash equity and equity-linked products. The firm also structures, originates and distributes new equity and equity-linked issues.